Clinical Trial VICCPED1251


Supplemental Empiric Antibiotics in Unstable Febrile Neutropenia: Indications and Outcomes - CHART REVIEW

Principal Investigator(s)

Adam Esbenshade


  • Protocol No. VICCPED1251
  • Open Date: 05/31/2012
  • Staging: NA
  • Age Group: Both Child and Adult
  • Scope: Local
  • Objective: Determine which symptoms traditionally associated with systemic compromise (hypotension change in mental status, rigors, and chills) best predict bacteremia in pediatric cancer patients presenting with neutropenic fever.
  • Disease Sites: Pediatrics
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.